Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Zuoxiang Liu"'
Autor:
Pei Li, Xueyang Zeng, Zuoxiang Liu, Jichun Yang, Yueying Li, Le Gao, Hongmei Zeng, Lin Zhang, Feng Sun, Yuanyuan Ji
Publikováno v:
Chinese Medical Journal, Vol 137, Iss 12, Pp 1471-1473 (2024)
Externí odkaz:
https://doaj.org/article/536d4f79af0c4d4eb124384f5fad2dd5
Autor:
Yu Yang, Liang Zhang, Susanne Hartwig, Peng Jiang, Houyu Zhao, Ruogu Meng, Zhike Liu, Zuoxiang Liu, Keqin Ding, Xuedan You, Carol Koro, Guozhang Xu, Siyan Zhan
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
The 4-valent (4 v) and 9-valent (9 v) human papillomavirus (HPV) vaccines are approved in China for females aged 9–45 years. However, the real-world impact of 4vHPV or 9vHPV vaccination for the prevention of high-grade cervical disease in Chinese w
Externí odkaz:
https://doaj.org/article/d7cccfcf4f344d8db5b9d9bc82fa8d22
Autor:
Ruogu Meng, Rui Ma, Jianmei Wang, Peipei Liu, Zuoxiang Liu, Bingjie He, Zhike Liu, Yu Yang, Siyan Zhan
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 696-703 (2023)
Background The 9-valent human papillomavirus (9vHPV) vaccine was introduced in China in 2018. This study was conducted to monitor the occurrence of new-onset autoimmune diseases (AIs) in Chinese women vaccinated with the 9vHPV vaccine and adverse pre
Externí odkaz:
https://doaj.org/article/30e45fddc6534d49a27dae9e5dcb5bad
Publikováno v:
Chinese Medical Journal, Vol 136, Iss 1, Pp 102-104 (2023)
Externí odkaz:
https://doaj.org/article/06e01b26a1ea4e99afa8b69a4ec8af27
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Aim: This study aims to investigate the association between the use of dipeptidyl peptidase-4 inhibitors (DPP-4i), glucagon-like peptide-1 receptor agonists (GLP-1 RAs), or sodium-glucose cotransporter-2 inhibitors (SGLT-2i) and the risk of fracture
Externí odkaz:
https://doaj.org/article/bf114b53472146beb169dbfc921b3848
Autor:
Yuxi Jin, Dandan Wei, Pengling Liu, Fei Chen, Rongrong Li, Jinyu Zhang, Ruyi Zhang, Zuoxiang Liu, Wenqian Huo, Linlin Li, Chongjian Wang, Jinbao Ban, Zhenxing Mao
Publikováno v:
International Journal of Endocrinology, Vol 2022 (2022)
Background and Aims. The effects of cortisol on cardiovascular diseases (CVD) and CVD risk are unknown, especially in patients with type 2 diabetes mellitus (T2DM). Furthermore, it is unclear whether 25 (OH)D can alter the associations of cortisol wi
Externí odkaz:
https://doaj.org/article/b554899a747c4173922be55c69764998
Autor:
Haibo Song, Xiaojing Pei, Zuoxiang Liu, Chuanyong Shen, Jun Sun, Yuqin Liu, Lingyun Zhou, Feng Sun, Xiaohe Xiao
Publikováno v:
British journal of clinical pharmacologyREFERENCES.
Drug-related adverse reactions are among the main reasons for harm to patients under care worldwide and even their deaths. The pharmacovigilance system has been proven to be an effective method of avoiding or alleviating such adverse events. In 2019,
There is limited comprehensive evaluation of the methodology and reporting quality of observational studies of vaccine safety. Databases including Medline, Embase, Web of Science, Scopus, and Chinese databases were searched from inception to 31 May 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c023b791e669fe686ef62736b8601d55
Autor:
Haibo Song, Xiaojing Pei, Zuoxiang Liu, Chuanyong Shen, Jun Sun, Yuqin Liu, Lingyun Zhou, Sun Feng, Xiaohe Xiao
Drug-related adverse reactions are among the main reasons for harm to patients under care worldwide and even their deaths. The pharmacovigilance system has been proven to be an effective method of avoiding or alleviating such adverse events. In 2019,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71d17e7cfa4f6d8485e96d66fa1c5e1d
https://doi.org/10.22541/au.163483847.79222435/v1
https://doi.org/10.22541/au.163483847.79222435/v1
Autor:
Zuoxiang Liu, Qilin Ding
Publikováno v:
CSO (2)
Cheaper land, cheaper labor, cheaper capital and convenient mass transportation are determinants of auto industrial location in a completely competitive market. Empirically, Changsha, a city locating in the centre of south China and crossing two main